Cell Viability Assays Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Cell Viability Assays Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell Viability Assays Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell Viability Assays Overall Market Size
2.1 Global Cell Viability Assays Market Size: 2021 VS 2027
2.2 Global Cell Viability Assays Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell Viability Assays Players in Global Market
3.2 Top Global Cell Viability Assays Companies Ranked by Revenue
3.3 Global Cell Viability Assays Revenue by Companies
3.4 Top 3 and Top 5 Cell Viability Assays Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cell Viability Assays Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell Viability Assays Players in Global Market
3.6.1 List of Global Tier 1 Cell Viability Assays Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell Viability Assays Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell Viability Assays Market Size Markets, 2021 & 2027
4.1.2 Human Cells
4.1.3 Microbial Cells
4.1.4 Animal Cells
4.2 By Type - Global Cell Viability Assays Revenue & Forecasts
4.2.1 By Type - Global Cell Viability Assays Revenue, 2016-2021
4.2.2 By Type - Global Cell Viability Assays Revenue, 2022-2027
4.2.3 By Type - Global Cell Viability Assays Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell Viability Assays Market Size, 2021 & 2027
5.1.2 Pharmaceutical and Biotechnology Companies
5.1.3 Academic and Research Institutes
5.1.4 Hospital and Diagnostic Laboratories
5.1.5 Others
5.2 By Application - Global Cell Viability Assays Revenue & Forecasts
5.2.1 By Application - Global Cell Viability Assays Revenue, 2016-2021
5.2.2 By Application - Global Cell Viability Assays Revenue, 2022-2027
5.2.3 By Application - Global Cell Viability Assays Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Cell Viability Assays Market Size, 2021 & 2027
6.2 By Region - Global Cell Viability Assays Revenue & Forecasts
6.2.1 By Region - Global Cell Viability Assays Revenue, 2016-2021
6.2.2 By Region - Global Cell Viability Assays Revenue, 2022-2027
6.2.3 By Region - Global Cell Viability Assays Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Cell Viability Assays Revenue, 2016-2027
6.3.2 US Cell Viability Assays Market Size, 2016-2027
6.3.3 Canada Cell Viability Assays Market Size, 2016-2027
6.3.4 Mexico Cell Viability Assays Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Cell Viability Assays Revenue, 2016-2027
6.4.2 Germany Cell Viability Assays Market Size, 2016-2027
6.4.3 France Cell Viability Assays Market Size, 2016-2027
6.4.4 U.K. Cell Viability Assays Market Size, 2016-2027
6.4.5 Italy Cell Viability Assays Market Size, 2016-2027
6.4.6 Russia Cell Viability Assays Market Size, 2016-2027
6.4.7 Nordic Countries Cell Viability Assays Market Size, 2016-2027
6.4.8 Benelux Cell Viability Assays Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Cell Viability Assays Revenue, 2016-2027
6.5.2 China Cell Viability Assays Market Size, 2016-2027
6.5.3 Japan Cell Viability Assays Market Size, 2016-2027
6.5.4 South Korea Cell Viability Assays Market Size, 2016-2027
6.5.5 Southeast Asia Cell Viability Assays Market Size, 2016-2027
6.5.6 India Cell Viability Assays Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Cell Viability Assays Revenue, 2016-2027
6.6.2 Brazil Cell Viability Assays Market Size, 2016-2027
6.6.3 Argentina Cell Viability Assays Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell Viability Assays Revenue, 2016-2027
6.7.2 Turkey Cell Viability Assays Market Size, 2016-2027
6.7.3 Israel Cell Viability Assays Market Size, 2016-2027
6.7.4 Saudi Arabia Cell Viability Assays Market Size, 2016-2027
6.7.5 UAE Cell Viability Assays Market Size, 2016-2027
7 Players Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Corporate Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Cell Viability Assays Major Product Offerings
7.1.4 Thermo Fisher Scientific Cell Viability Assays Revenue in Global (2016-2021)
7.1.5 Thermo Fisher Scientific Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Cell Viability Assays Major Product Offerings
7.2.4 Merck Cell Viability Assays Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 Bio-Rad
7.3.1 Bio-Rad Corporate Summary
7.3.2 Bio-Rad Business Overview
7.3.3 Bio-Rad Cell Viability Assays Major Product Offerings
7.3.4 Bio-Rad Cell Viability Assays Revenue in Global (2016-2021)
7.3.5 Bio-Rad Key News
7.4 GE
7.4.1 GE Corporate Summary
7.4.2 GE Business Overview
7.4.3 GE Cell Viability Assays Major Product Offerings
7.4.4 GE Cell Viability Assays Revenue in Global (2016-2021)
7.4.5 GE Key News
7.5 Danaher
7.5.1 Danaher Corporate Summary
7.5.2 Danaher Business Overview
7.5.3 Danaher Cell Viability Assays Major Product Offerings
7.5.4 Danaher Cell Viability Assays Revenue in Global (2016-2021)
7.5.5 Danaher Key News
7.6 BD
7.6.1 BD Corporate Summary
7.6.2 BD Business Overview
7.6.3 BD Cell Viability Assays Major Product Offerings
7.6.4 BD Cell Viability Assays Revenue in Global (2016-2021)
7.6.5 BD Key News
7.7 PerkinElmer
7.7.1 PerkinElmer Corporate Summary
7.7.2 PerkinElmer Business Overview
7.7.3 PerkinElmer Cell Viability Assays Major Product Offerings
7.4.4 PerkinElmer Cell Viability Assays Revenue in Global (2016-2021)
7.7.5 PerkinElmer Key News
7.8 Promega
7.8.1 Promega Corporate Summary
7.8.2 Promega Business Overview
7.8.3 Promega Cell Viability Assays Major Product Offerings
7.8.4 Promega Cell Viability Assays Revenue in Global (2016-2021)
7.8.5 Promega Key News
7.9 Biotium
7.9.1 Biotium Corporate Summary
7.9.2 Biotium Business Overview
7.9.3 Biotium Cell Viability Assays Major Product Offerings
7.9.4 Biotium Cell Viability Assays Revenue in Global (2016-2021)
7.9.5 Biotium Key News
7.10 Abcam
7.10.1 Abcam Corporate Summary
7.10.2 Abcam Business Overview
7.10.3 Abcam Cell Viability Assays Major Product Offerings
7.10.4 Abcam Cell Viability Assays Revenue in Global (2016-2021)
7.10.5 Abcam Key News
7.11 Creative Bioarray
7.11.1 Creative Bioarray Corporate Summary
7.11.2 Creative Bioarray Business Overview
7.11.3 Creative Bioarray Cell Viability Assays Major Product Offerings
7.11.4 Creative Bioarray Cell Viability Assays Revenue in Global (2016-2021)
7.11.5 Creative Bioarray Key News
7.12 Biotek Instruments
7.12.1 Biotek Instruments Corporate Summary
7.12.2 Biotek Instruments Business Overview
7.12.3 Biotek Instruments Cell Viability Assays Major Product Offerings
7.12.4 Biotek Instruments Cell Viability Assays Revenue in Global (2016-2021)
7.12.5 Biotek Instruments Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Cell Viability Assays Market Opportunities & Trends in Global Market
Table 2. Cell Viability Assays Market Drivers in Global Market
Table 3. Cell Viability Assays Market Restraints in Global Market
Table 4. Key Players of Cell Viability Assays in Global Market
Table 5. Top Cell Viability Assays Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cell Viability Assays Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cell Viability Assays Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cell Viability Assays Product Type
Table 9. List of Global Tier 1 Cell Viability Assays Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell Viability Assays Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Cell Viability Assays Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cell Viability Assays Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cell Viability Assays Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Cell Viability Assays Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cell Viability Assays Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cell Viability Assays Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Cell Viability Assays Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cell Viability Assays Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cell Viability Assays Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cell Viability Assays Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cell Viability Assays Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cell Viability Assays Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cell Viability Assays Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cell Viability Assays Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cell Viability Assays Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cell Viability Assays Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cell Viability Assays Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cell Viability Assays Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cell Viability Assays Revenue, (US$, Mn), 2022-2027
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Cell Viability Assays Product Offerings
Table 32. Thermo Fisher Scientific Cell Viability Assays Revenue (US$, Mn), (2016-2021)
Table 33. Merck Corporate Summary
Table 34. Merck Cell Viability Assays Product Offerings
Table 35. Merck Cell Viability Assays Revenue (US$, Mn), (2016-2021)
Table 36. Bio-Rad Corporate Summary
Table 37. Bio-Rad Cell Viability Assays Product Offerings
Table 38. Bio-Rad Cell Viability Assays Revenue (US$, Mn), (2016-2021)
Table 39. GE Corporate Summary
Table 40. GE Cell Viability Assays Product Offerings
Table 41. GE Cell Viability Assays Revenue (US$, Mn), (2016-2021)
Table 42. Danaher Corporate Summary
Table 43. Danaher Cell Viability Assays Product Offerings
Table 44. Danaher Cell Viability Assays Revenue (US$, Mn), (2016-2021)
Table 45. BD Corporate Summary
Table 46. BD Cell Viability Assays Product Offerings
Table 47. BD Cell Viability Assays Revenue (US$, Mn), (2016-2021)
Table 48. PerkinElmer Corporate Summary
Table 49. PerkinElmer Cell Viability Assays Product Offerings
Table 50. PerkinElmer Cell Viability Assays Revenue (US$, Mn), (2016-2021)
Table 51. Promega Corporate Summary
Table 52. Promega Cell Viability Assays Product Offerings
Table 53. Promega Cell Viability Assays Revenue (US$, Mn), (2016-2021)
Table 54. Biotium Corporate Summary
Table 55. Biotium Cell Viability Assays Product Offerings
Table 56. Biotium Cell Viability Assays Revenue (US$, Mn), (2016-2021)
Table 57. Abcam Corporate Summary
Table 58. Abcam Cell Viability Assays Product Offerings
Table 59. Abcam Cell Viability Assays Revenue (US$, Mn), (2016-2021)
Table 60. Creative Bioarray Corporate Summary
Table 61. Creative Bioarray Cell Viability Assays Product Offerings
Table 62. Creative Bioarray Cell Viability Assays Revenue (US$, Mn), (2016-2021)
Table 63. Biotek Instruments Corporate Summary
Table 64. Biotek Instruments Cell Viability Assays Product Offerings
Table 65. Biotek Instruments Cell Viability Assays Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Cell Viability Assays Segment by Type
Figure 2. Cell Viability Assays Segment by Application
Figure 3. Global Cell Viability Assays Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cell Viability Assays Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cell Viability Assays Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell Viability Assays Revenue in 2020
Figure 8. By Type - Global Cell Viability Assays Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cell Viability Assays Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cell Viability Assays Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cell Viability Assays Revenue Market Share, 2016-2027
Figure 12. US Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cell Viability Assays Revenue Market Share, 2016-2027
Figure 16. Germany Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 17. France Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cell Viability Assays Revenue Market Share, 2016-2027
Figure 24. China Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 28. India Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cell Viability Assays Revenue Market Share, 2016-2027
Figure 30. Brazil Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cell Viability Assays Revenue Market Share, 2016-2027
Figure 33. Turkey Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cell Viability Assays Revenue, (US$, Mn), 2016-2027
Figure 37. Thermo Fisher Scientific Cell Viability Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Merck Cell Viability Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bio-Rad Cell Viability Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. GE Cell Viability Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Danaher Cell Viability Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. BD Cell Viability Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. PerkinElmer Cell Viability Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Promega Cell Viability Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Biotium Cell Viability Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Abcam Cell Viability Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Creative Bioarray Cell Viability Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Biotek Instruments Cell Viability Assays Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Thermo Fisher Scientific
Merck
Bio-Rad
GE
Danaher
BD
PerkinElmer
Promega
Biotium
Abcam
Creative Bioarray
Biotek Instruments